CCIA
MIRM icon

Campbell & Co Investment Adviser’s Mirum Pharmaceuticals MIRM Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-23,566
Closed -$1.73M – 1298
2025
Q3 		$1.73M Buy
+23,566
New +$1.5M 0.13% 229
2025
Q2 		– Sell
-25,944
Closed -$1.17M – 1333
2025
Q1 		$1.17M Buy
25,944
+9,777
+60% +$461K 0.09% 365
2024
Q4 		$669K Buy
+16,167
New +$674K 0.05% 548
2024
Q3 		– Sell
-6,439
Closed -$220K – 1238
2024
Q2 		$220K Buy
+6,439
New +$169K 0.02% 941
2024
Q1 		– Sell
-10,411
Closed -$307K – 1275
2023
Q4 		$307K Sell
10,411
-18,145
-64% -$549K 0.03% 909
2023
Q3 		$902K Buy
28,556
+13,582
+91% +$372K 0.11% 301
2023
Q2 		$387K Buy
+14,974
New +$398K 0.07% 551

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Campbell & Co Investment Adviser's MIRM Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Mirum Pharmaceuticals (MIRM) in Q4 2025, closing a stake of 23,566 shares — an estimated $1.73M sold.

Campbell & Co Investment Adviser first reported a position in MIRM in Q2 2023 and held it in 7 quarters. The position peaked at $1.73M in Q3 2025. 281 funds tracked by Wall St. Rank hold MIRM as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining Mirum Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 23,566 Mirum Pharmaceuticals shares in Q4 2025, an estimated $1.73M.
  • Campbell & Co Investment Adviser first reported a position in Mirum Pharmaceuticals in Q2 2023 and held it in 7 quarters.
  • Campbell & Co Investment Adviser's Mirum Pharmaceuticals position peaked at $1.73M in Q3 2025.
  • 281 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.